Are bacterial infections a major cause of cardiovascular disease?
作者信息
Kissinger Dohn
机构信息
Independent Researcher, El Dorado Hills, CA, United States.
出版信息
Front Cardiovasc Med. 2024 Sep 4;11:1389109. doi: 10.3389/fcvm.2024.1389109. eCollection 2024.
Abstract
摘要
相似文献
1
Are bacterial infections a major cause of cardiovascular disease?细菌感染是心血管疾病的主要病因吗？
Front Cardiovasc Med. 2024 Sep 4;11:1389109. doi: 10.3389/fcvm.2024.1389109. eCollection 2024.
2
Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.在管理式医疗环境中，以低高密度脂蛋白胆固醇为靶点降低残余心血管风险。
J Manag Care Pharm. 2008 Oct;14(8 Suppl):S3-28; quiz S30-1.
3
Comparison of on-Statin Lipid and Lipoprotein Levels for the Prediction of First Cardiovascular Event in Type 2 Diabetes Mellitus.比较他汀类药物治疗下的血脂和脂蛋白水平对 2 型糖尿病患者首发心血管事件的预测作用。
Diabetes Metab J. 2023 Nov;47(6):837-845. doi: 10.4093/dmj.2022.0217. Epub 2023 Aug 23.
4
Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis.他汀类药物治疗患者的 LDL 胆固醇、非 HDL 胆固醇和载脂蛋白 B 水平与心血管事件风险的关系：一项荟萃分析。
JAMA. 2012 Mar 28;307(12):1302-9. doi: 10.1001/jama.2012.366.
5
Discordance of Circulating Non-HDL Cholesterol with LDL Cholesterol Concerning Long-Term Prognosis in Statin-Treated Individuals with Acute Coronary Syndrome and Previous Coronary Artery Bypass Grafting Undergoing Percutaneous Coronary Intervention.在接受经皮冠状动脉介入治疗的急性冠状动脉综合征且既往有冠状动脉旁路移植术的他汀类药物治疗患者中，循环中非高密度脂蛋白胆固醇与低密度脂蛋白胆固醇在长期预后方面的不一致性。
Rev Cardiovasc Med. 2023 Sep 21;24(9):263. doi: 10.31083/j.rcm2409263. eCollection 2023 Sep.
6
Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials.极低水平的致动脉粥样硬化脂蛋白与心血管事件风险：他汀类药物试验的荟萃分析。
J Am Coll Cardiol. 2014 Aug 5;64(5):485-94. doi: 10.1016/j.jacc.2014.02.615.
7
Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.美国接受他汀类药物治疗成年人中根据低密度脂蛋白胆固醇、非高密度脂蛋白胆固醇和载脂蛋白B划分的残余血脂异常：2009 - 2010年美国国家健康和营养检查调查
J Clin Lipidol. 2015 Jul-Aug;9(4):525-32. doi: 10.1016/j.jacl.2015.05.003. Epub 2015 May 16.
8
Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.他汀类药物治疗的糖尿病患者存在严重的高三酰甘油血症和残余血脂异常，这些患者心血管疾病风险最高，且达到非常低的 LDL-C 水平。
J Clin Lipidol. 2012 Sep-Oct;6(5):434-42. doi: 10.1016/j.jacl.2012.04.002. Epub 2012 Apr 12.
9
Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.管理他汀类药物治疗患者与高密度脂蛋白胆固醇和甘油三酯相关的残余心血管疾病风险：临床更新。
Nutr Metab Cardiovasc Dis. 2013 Sep;23(9):799-807. doi: 10.1016/j.numecd.2013.05.002. Epub 2013 Aug 9.
10
The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.他汀类药物治疗期间提高高密度脂蛋白胆固醇的有益效果取决于低密度脂蛋白胆固醇所达到的水平：对冠状动脉粥样硬化进展和心血管事件的影响。
Eur J Prev Cardiol. 2016 Mar;23(5):474-85. doi: 10.1177/2047487315572920. Epub 2015 Feb 17.
本文引用的文献
1
Association of Low-Density Lipoprotein Cholesterol Levels with More than 20-Year Risk of Cardiovascular and All-Cause Mortality in the General Population.低密度脂蛋白胆固醇水平与普通人群 20 多年心血管和全因死亡率的关系。
J Am Heart Assoc. 2022 Aug 2;11(15):e023690. doi: 10.1161/JAHA.121.023690. Epub 2022 Jul 29.
2
Helicobacter pylori infection and the progression of atherosclerosis: A systematic review and meta-analysis.幽门螺杆菌感染与动脉粥样硬化的进展：一项系统评价和荟萃分析。
Helicobacter. 2022 Feb;27(1):e12865. doi: 10.1111/hel.12865. Epub 2021 Nov 28.
3
Association between helicobacter pylori infection and subclinical atherosclerosis: A systematic review and meta-analysis.幽门螺杆菌感染与亚临床动脉粥样硬化的关系：系统评价和荟萃分析。
Medicine (Baltimore). 2021 Nov 19;100(46):e27840. doi: 10.1097/MD.0000000000027840.
4
The association of Chlamydia pneumoniae infection with atherosclerosis: Review and update of in vitro and animal studies.肺炎衣原体感染与动脉粥样硬化的关系：体外和动物研究的回顾与更新。
Microb Pathog. 2021 May;154:104803. doi: 10.1016/j.micpath.2021.104803. Epub 2021 Feb 17.
5
Inpatient and Outpatient Infection as a Trigger of Cardiovascular Disease: The ARIC Study.住院和门诊感染作为心血管疾病的触发因素：ARIC 研究。
J Am Heart Assoc. 2018 Nov 20;7(22):e009683. doi: 10.1161/JAHA.118.009683.
6
Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease.依维莫司和高危血管疾病的心血管结局。
N Engl J Med. 2017 May 18;376(20):1933-1942. doi: 10.1056/NEJMoa1609581.
7
Gut Microbiota in Cardiovascular Health and Disease.肠道微生物群与心血管健康和疾病
Circ Res. 2017 Mar 31;120(7):1183-1196. doi: 10.1161/CIRCRESAHA.117.309715.
8
Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review.老年人中低密度脂蛋白胆固醇与死亡率之间缺乏关联或呈负相关：一项系统综述。
BMJ Open. 2016 Jun 12;6(6):e010401. doi: 10.1136/bmjopen-2015-010401.
9
Helicobacter pylori Infection and atherosclerosis: a systematic review.幽门螺杆菌感染与动脉粥样硬化：一项系统综述。
Acta Med Iran. 2015;53(2):78-88.
10
Promotion of atherosclerosis by Helicobacter cinaedi infection that involves macrophage-driven proinflammatory responses.嗜沫栖热放线菌感染通过巨噬细胞驱动的促炎反应促进动脉粥样硬化。
Sci Rep. 2014 Apr 15;4:4680. doi: 10.1038/srep04680.
Zotero 插件